SPONSOR
Roswell Park Cancer Institute
Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 1
Conditions studied: Extensive Stage Lung Small Cell CarcinomaBasal Cell CarcinomaDigestive System Neuroendocrine NeoplasmLung Neuroendocrine NeoplasmMalignant Solid NeoplasmPancreatic Neuroendocrine NeoplasmStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8
Roswell Park Cancer Institute is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Extensive Stage Lung Small Cell Carcinoma, Basal Cell Carcinoma, Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Roswell Park Cancer Institute
How many clinical trials has Roswell Park Cancer Institute sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Roswell Park Cancer Institute, of which 13 are actively recruiting participants. These trials cover conditions including Extensive Stage Lung Small Cell Carcinoma, Basal Cell Carcinoma, Digestive System Neuroendocrine Neoplasm. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Roswell Park Cancer Institute research focus on?
Roswell Park Cancer Institute clinical trials span Extensive Stage Lung Small Cell Carcinoma, Basal Cell Carcinoma, Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Malignant Solid Neoplasm, and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Roswell Park Cancer Institute clinical trial?
To participate in a Roswell Park Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Roswell Park Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Roswell Park Cancer Institute
NCT04696575 Phase 2
Recruiting
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Extensive Stage Lung Small Cell Carcinoma
NCT07182240
Recruiting
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
Basal Cell Carcinoma
NCT06202066 Phase 2
Recruiting
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Digestive System Neuroendocrine Neoplasm
NCT04067830 Phase 2
Recruiting
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Stage I Lung Cancer AJCC v8
NCT07402577
Recruiting
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Sarcoma
NCT06863402 Phase 2
Recruiting
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Richter Syndrome
NCT06305598 Phase 1
Recruiting
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Castration-Resistant Prostate Carcinoma
NCT06798701
Recruiting
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation
Hematopoietic and Lymphatic System Neoplasm
NCT06855706
Recruiting
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
Endometrial Carcinoma
NCT07107139
Recruiting
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
Smokeless Tobacco
NCT04348747 Phase 2
Recruiting
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8
NCT05312255
Recruiting
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Plasma Cell Myeloma
NCT04682158 Phase 2
Recruiting
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
Esophageal Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology